Suppr超能文献

哌替啶对猫肺血管床的影响。

The effects of meperidine in the pulmonary vascular bed of the cat.

作者信息

Kaye Alan D, Hoover Jason M, Baber Syed R, Ibrahim Ikhlass N, Phelps James, Fields Aaron, Baluch Amir, Huffman Shane

机构信息

Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.

出版信息

J Cardiothorac Vasc Anesth. 2006 Oct;20(5):691-5. doi: 10.1053/j.jvca.2005.10.003. Epub 2006 Feb 8.

Abstract

OBJECTIVE

The purpose of this study was to test the hypothesis that meperidine induces a dilator response in the feline pulmonary vascular bed, and to identify receptors involved in the mediation or modulation of these effects.

DESIGN

Prospective vehicle controlled study.

SETTING

University research laboratory.

SUBJECTS

Intact chest preparation; adult mongrel cats.

INTERVENTIONS

In separate experiments, the effects of diphenydramine (histamine H(1)-receptor antagonist), glibenclamide (adenosine triphosphate-sensitive K+ channel blocker), L-N(5)-(1-Iminoethyl) ornithine hydrochloride (L-NIO) (nitric oxide synthase inhibitor), naloxone (opioid receptor antagonist), and nimesulide (selective cyclooxygenase-2 inhibitor) were investigated on pulmonary arterial responses to meperidine and other agonists in the feline lung bed.

MEASUREMENTS AND MAIN RESULTS

The systemic pressure and lobar arterial perfusion pressure were continuously monitored, electronically averaged, and permanently recorded. Under elevated tone conditions in the isolated left lower lobe vascular bed of the cat, meperidine induced a dose-dependent vasodilator response that was not significantly altered after administration of glibenclamide, L-NIO, and nimesulide. Responses to meperidine were significantly attenuated after the administration of diphenydramine and naloxone.

CONCLUSIONS

The results suggest that meperidine has potent vasodilator activity in the feline pulmonary vascular bed, and these responses are mediated or modulated, in part, by opioid and histamine receptor-sensitive pathways.

摘要

目的

本研究旨在验证哌替啶可使猫肺血管床产生扩张反应这一假说,并确定介导或调节这些效应的受体。

设计

前瞻性对照研究。

地点

大学研究实验室。

对象

完整胸腔制备;成年杂种猫。

干预措施

在单独的实验中,研究了苯海拉明(组胺H(1)受体拮抗剂)、格列本脲(三磷酸腺苷敏感性钾通道阻滞剂)、L-N(5)-(1-亚氨基乙基)鸟氨酸盐酸盐(L-NIO)(一氧化氮合酶抑制剂)、纳洛酮(阿片受体拮抗剂)和尼美舒利(选择性环氧化酶-2抑制剂)对猫肺血管床中哌替啶及其他激动剂引起的肺动脉反应的影响。

测量指标及主要结果

持续监测体循环压力和叶动脉灌注压力,进行电子平均并永久记录。在猫离体左下叶血管床张力升高的情况下,哌替啶可引起剂量依赖性血管舒张反应,给予格列本脲、L-NIO和尼美舒利后该反应无明显改变。给予苯海拉明和纳洛酮后,对哌替啶的反应显著减弱。

结论

结果表明哌替啶在猫肺血管床具有强大的血管舒张活性,且这些反应部分由阿片和组胺受体敏感途径介导或调节。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验